Catalyst Pharmaceuticals Inc (CPRX)
16.14
-0.39
(-2.36%)
USD |
NASDAQ |
May 22, 16:00
16.49
+0.35
(+2.17%)
After-Hours: 07:56
Catalyst Pharmaceuticals Accounts Receivable (Quarterly): 60.49M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 60.49M |
| December 31, 2023 | 53.51M |
| September 30, 2023 | 48.05M |
| June 30, 2023 | 42.80M |
| March 31, 2023 | 33.40M |
| December 31, 2022 | 10.44M |
| September 30, 2022 | 9.337M |
| June 30, 2022 | 9.587M |
| March 31, 2022 | 10.55M |
| December 31, 2021 | 6.619M |
| September 30, 2021 | 6.625M |
| Date | Value |
|---|---|
| June 30, 2021 | 6.292M |
| March 31, 2021 | 5.601M |
| December 31, 2020 | 5.987M |
| September 30, 2020 | 5.872M |
| June 30, 2020 | 6.762M |
| March 31, 2020 | 6.919M |
| December 31, 2019 | 10.54M |
| September 30, 2019 | 10.10M |
| June 30, 2019 | 10.38M |
| March 31, 2019 | 7.251M |
| December 31, 2018 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
5.601M
Minimum
Mar 2021
60.49M
Maximum
Mar 2024
17.99M
Average
9.841M
Median
Accounts Receivable (Quarterly) Benchmarks
| Pfizer Inc | 10.99B |
| Sarepta Therapeutics Inc | 378.81M |
| PTC Therapeutics Inc | 197.66M |
| Corcept Therapeutics Inc | 61.52M |
| Cytokinetics Inc | 0.834M |